Pular para o conteúdo
Merck
  • Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women.

Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women.

American journal of epidemiology (2013-06-01)
Nancy N Maserejian, Carrie G Wager, Edward L Giovannucci, Teresa M Curto, Kevin T McVary, John B McKinlay
RESUMO

Evidence to substantiate recommendations for restriction of caffeinated or acidic beverages as self-management for lower urinary tract symptoms (LUTS) is limited. We examined longitudinal and acute associations between beverage intake and LUTS in the Boston Area Community Health (BACH) cohort (n = 4,144) between 2002 and 2010. Multivariable models tested associations between baseline intakes and progression of LUTS at 5-year follow-up, between follow-up intakes and International Prostate Symptom Scores at follow-up, and between 5-year intake changes and LUTS progression. Greater coffee or total caffeine intake at baseline increased the odds of LUTS progression in men (coffee: >2 cups/day vs. none, odds ratio = 2.09, 95% confidence interval: 1.29, 3.40, P-trend = 0.01; caffeine: P-trend < 0.001), particularly storage symptoms. Women who increased coffee intake by at least 2 servings/day during follow-up (compared with categories of decreased or unchanged intakes) had 64% higher odds of progression of urgency (P = 0.003). Women with recently increased soda intake, particularly caffeinated diet soda, had higher symptom scores, urgency, and LUTS progression. Citrus juice intake was associated with 50% lower odds of LUTS progression in men (P = 0.02). Findings support recommendations to limit caffeinated beverage intake for LUTS, and in men, they suggest benefits of citrus juice consumption. Further clinical research is warranted, particularly of the precise role of sodas containing artificial sweeteners in bladder sensations and urological function.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Cafeína, anhydrous, 99%, FCC, FG
Sigma-Aldrich
Cafeína, powder, ReagentPlus®
Supelco
Cafeína, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Caffeine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Cafeína, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Cafeína, Sigma Reference Standard, vial of 250 mg
Supelco
Cafeína, analytical standard
Supelco
Cafeína, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Caffeine solution, analytical standard, 1.0 mg/mL in methanol
Sigma-Aldrich
Cafeína, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
Cafeína, meets USP testing specifications, anhydrous
Supelco
Cafeína, traceable to primary standards (LGC)
Sigma-Aldrich
Cafeína, BioXtra
Cafeína, European Pharmacopoeia (EP) Reference Standard
Cafeína, European Pharmacopoeia (EP) Reference Standard